48 Results for "

orexin receptor antagonist

" in MedChemExpress (MCE) Product Catalog:
Products (48)

48 Results for "orexin receptor antagonist" in MCE Product Catalog:

14
14 Publications Verification
Cat. No.: HY-10895
CAS No.: 249889-64-3
Synonyms: SB 334867A
SB-334867 (SB 334867A) is an excellent,selective and blood-brain barrier permeable orexin-1 (OX1) receptor antagonist, shows selectivity over OX2 (pKb=7.4), 100-fold over 5-HT2B, 5-HT2C with pKi values of 5.4 and 5.3, respectively . SB-334867 reduces ethanol consumption and inhibits the acquisition of morphine-induced sensitization to locomotor activity in vivo .
loading...
    loading...
14
14 Publications Verification
Cat. No.: HY-108682
CAS No.: 680590-49-2
Purity:  99.92%
Research Areas:  

Neurological Disease

EMPA is a high-affinity, reversible and selective orexin OX2 receptor antagonist. [ 3H]EMPA binds to human and rat OX2-HEK293 membranes with KD values of 1.1 and 1.4 nM respectively .
loading...
    loading...
14
14 Publications Verification
Cat. No.: HY-10895A
CAS No.: 792173-99-0
Purity:  99.88%
Synonyms: SB334867A free base
SB-334867 free base (SB334867A free base) is an excellent, selective and blood–brain barrier permeable orexin-1 (OX1) receptor antagonist, shows selectivity over OX2 (pKb=7.4), 100-fold over 5-HT2B, 5-HT2C with pKi values of 5.4 and 5.3, respectively . SB-334867 reduces ethanol consumption and inhibits the acquisition of morphine-induced sensitization to locomotor activity in vivo .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-10805
CAS No.: 871224-64-5
Purity:  99.46%
Synonyms: ACT 078573
Almorexant (ACT 078573) is an orally active, potent and competitive dual orexin receptor antagonist, with Kd values of 1.3 nM (OX1) and 0.17 nM (OX2), respectively. Almorexant reversibly blocks signaling of orexin-A and orexin-B peptides. Almorexant totally blocked the intracellular Ca 2+ signal pathway. Almorexant stimulates caspase-3 activity in AsPC-1 cells and induces apoptosis .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-10805A
CAS No.: 913358-93-7
Purity:  99.98%
Synonyms: ACT 078573 hydrochloride
Almorexant (ACT 078573) hydrochloride is an orally active, potent and competitive dual orexin receptor antagonist, with Kd values of 1.3 nM (OX1) and 0.17 nM (OX2), respectively. Almorexant hydrochloride reversibly blocks signaling of orexin-A and orexin-B peptides. Almorexant hydrochloride totally blocked the intracellular Ca 2+ signal pathway. Almorexant hydrochloride stimulates caspase-3 activity in AsPC-1 cells and induces apoptosis .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-109012
CAS No.: 1293281-49-8
Purity:  99.86%
Synonyms: JNJ-42847922
Seltorexant (JNJ-42847922) is an orally active, high-affinity, and selective orexin-2 receptor (OX2R) antagonist (pKi values of 8.0 and 8.1 for human and rat OX2R). Seltorexant (JNJ-42847922) crosses the blood-brain barrier and quickly occupies OX2R binding sites in the rat brain .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-100452
CAS No.: 372523-75-6
Purity:  99.55%
Research Areas:  

Endocrinology Cancer

TCS-OX2-29 is a potent, high affinities and selective orexin-2 receptor (OX2R) antagonist with an IC50 value of 40 nM and a pKI value of 7.5. TCS-OX2-29 displays ~250-fold selectivity for OX2 over OX1 .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10898
CAS No.: 483313-22-0
Purity:  99.93%
SB-674042 is a potent and selective non-peptide orexin OX1 receptor antagonist (Kd=5.03 nM), exhibits 100-fold selectivity for OX1 over OX2 receptors with IC50 values of 3.76 nM and 531 nM, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-10896
CAS No.: 708275-58-5
Purity:  99.91%
Research Areas:  

Neurological Disease

JNJ-10397049 is a potent and selective orexin 2 receptor (OX2R) antagonist, with a pKi of 8.3. JNJ-10397049 is 600-fold selective for the OX2R over the OX1R .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10900
CAS No.: 916141-36-1
Purity:  99.73%
TCS 1102 is a potent, dual orexin receptor antagonist, with Ki values of 0.2 nM and 3 nM for OX2 and OX1 receptors, respectively. TCS 1102 demonstrates excellent blood-brain barrier penetrability and moderate bioavailability in rats .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-137093
CAS No.: 1293282-55-9
Purity:  99.62%
Research Areas:  

Metabolic Disease

Orexin receptor antagonist 3 (example 216) is an orexin receptor antagonist, which is extracted from the patent WO2011050198A1 .
loading...
    loading...
Cat. No.: HY-152843
CAS No.: 1808918-69-5
Purity:  99.73%
Synonyms: YZJ-1139
Research Areas:  

Neurological Disease

Fazamorexant (YZJ-1139) is an orally active dual orexin receptor antagonist, with an IC50 of 32 nM against OX1R and an IC50 of 41 nM against OX2R. Fazamorexant prolongs total sleep time and improves sleep efficiency. Fazamorexant is applicable to related research on insomnia .
loading...
    loading...
Cat. No.: HY-101534
CAS No.: 1191044-58-2
Purity:  99.83%
GSK1059865 is a potent orexin 1 receptor antagonist.
loading...
    loading...
Cat. No.: HY-162235
CAS No.: 1803557-42-7
Research Areas:  

Cardiovascular Disease

CVN766 is an orally active inhibitor of orexin 1 receptor antagonist with blood-brain permeability with the IC50 values of 8 nM and >10 μM for OX1R and OX2R, respectively. CVN766 can be used for study schizophrenia .
loading...
    loading...
Cat. No.: HY-P1341
CAS No.: 343268-91-7
Synonyms: orexin A (17-33) (human, mouse, rat, bovine)
OXA (17-33) (Orexin A (17-33) (human, mouse, rat, bovine)) is the shortest active orexin peptide that selectively targets OX1 (EC50=8.29 nM), with 23-fold selectivity for the OX1 receptor over the OX2 receptor. The activity of OXA (17-33) depends on the Tyr17, Leu20, Asn25, His26 residues and the spatial conformation of the α-helix. OXA (17-33) activates signaling pathways involving inositol-1,4,5-trisphosphate receptor (IP3R), phospholipase D (PL-D) and choline-Sigma-1R, thereby increasing the cytoplasmic Ca 2+ level in nucleus accumbens neurons, an effect that is blocked by Sigma-1R antagonists. OXA (17-33) serves as an important biological probe for investigating the function of the OX1 receptor. OXA (17-33) can be modified via incorporation of mixed disulfide bonds of homocysteine and cysteamine, and is widely used in studies related to insomnia and narcolepsy .
loading...
    loading...
Cat. No.: HY-101834
CAS No.: 1361321-96-1
Purity:  99.60%
Research Areas:  

Others

ACT-462206 is an orally active and potent dual Orexin 1/Orexin 2 receptor antagonist with IC50s of 60 nM (Orexin 1) and 11 nM (Orexin 2), respectively. ACT-462206 exhibits brain penetration properties, and can be used for insomnia, stress/anxiety-related disorders and addiction research .
loading...
    loading...
Cat. No.: HY-134188
CAS No.: 1628843-99-1
Purity:  98.06%
Research Areas:  

Neurological Disease

JNJ-54717793, as a brain penetrant, is an orally active, selective and high affinity orexin-1 receptor (OX1R) antagonist (plasma EC50=85 ng/mL). The Ki values of JNJ-54717793 for hOX1R (human OX1R) and hOX2R are 16 nM and 700 nM, respectively. JNJ-54717793 is a potent compound of anxiety disorders .
loading...
    loading...
Cat. No.: HY-108683
CAS No.: 1354039-86-3
Purity:  ≥98.0%
Research Areas:  

Neurological Disease

ACT-335827 is a selective, orally active, brain-penetrant orexin type 1 receptor antagonist. ACT-33582 acts on OXR1 and OXR2 with IC50 values of 6 nM and 417 nM, respectively. ACT-33582 can be used in studies related to neurological disorders .
loading...
    loading...
Cat. No.: HY-136922
CAS No.: 1457940-75-8
Purity:  98.04%
Research Areas:  

Neurological Disease

Orexin receptor antagonist 2 (compound 30) is a potent orexin receptor antagonist with pKis of 7.69 and 9.78. Orexin receptor antagonist 2 has the potential for the research of insomnia .
loading...
    loading...
Cat. No.: HY-10806
CAS No.: 380899-24-1
Purity:  99.87%
Synonyms: GSK649868
SB-649868 is a potent and selective orally active orexin (OX) 1 and OX2 receptor antagonist (pKi =9.4 and 9.5 at the OX1 and OX2 receptor, respectively).
loading...
    loading...